Anti-TIGIT antibodies
US10766957B2 · kind B2 · utility
5Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 9, 2016 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Oct 9, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.